MedPath

Cetirizine Hydrochloride

Cetirizine Hydrochloride

Approved
Approval ID

eb917099-fecf-6b55-e053-2995a90aaafa

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 23, 2025

Manufacturers
FDA

Marlex Pharmaceuticals, Inc

DUNS: 782540215

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cetirizine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10135-762
Application NumberANDA077498
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cetirizine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 23, 2025
FDA Product Classification

INGREDIENTS (9)

POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
CETIRIZINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: 64O047KTOA
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 10/1/2022

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

NDC 10135-0762-05

Allergy Relief
Cetirizine HCl Tablets, USP 10 mg
ANTIHISTAMINE

500 TABLETS

0762-05

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 10/1/2022

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 10/1/2022

Manufactured for/ Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

Rev. 10/22 SP

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 10/1/2022

Active ingredient (in each tablet)

Cetirizine HCl, USP 10 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 10/1/2022

Purpose

Antihistamine

WARNINGS SECTION

LOINC: 34071-1Updated: 9/23/2025

Warnings

.

Do not useif you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you aretaking sedatives or tranquilizers.

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor ifan allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use.

**Keep out of reach of children.**In case of overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 10/1/2022

Directions

adults and children 6 years and over

one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.

adults 65 years and over

ask a doctor

children under 6 years of age

ask a doctor

consumers with liver or kidney disease

ask a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 10/1/2022

Other information

  • store between 20° and 25° C (68° and 77° F)
  • do not use if imprinted safety seal under cap is broken or missing.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 10/1/2022

Inactive ingredients

corn starch, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, talc, titanium dioxide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cetirizine Hydrochloride - FDA Drug Approval Details